FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 31 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $279,000 | -76.0% | 56,378 | -46.2% | 0.03% | -72.2% |
| Q4 2016 | $1,164,000 | +2.1% | 104,880 | -14.8% | 0.10% | -11.0% |
| Q3 2016 | $1,140,000 | +23.4% | 123,123 | -15.4% | 0.11% | -14.2% |
| Q2 2016 | $924,000 | +25.5% | 145,508 | +29.0% | 0.13% | +25.7% |
| Q1 2016 | $736,000 | -16.7% | 112,811 | +3.5% | 0.10% | -9.8% |
| Q4 2015 | $884,000 | +31.4% | 109,011 | +18.7% | 0.11% | +5.7% |
| Q3 2015 | $673,000 | -24.5% | 91,811 | +5.6% | 0.11% | -27.4% |
| Q2 2015 | $891,000 | +47.0% | 86,909 | +32.6% | 0.15% | +87.2% |
| Q1 2015 | $606,000 | – | 65,559 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
| GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
| Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
| Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
| DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
| RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
| SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
| Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
| Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
| NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |